WNK2 and breast cancer: Insulin receptor, once activated, will phosphorylate a number of intracellular proteins, leading to the activation of the extracellular signal-regulated kinase (ERK) cascade, one of the mitogen-activating protein kinase (MAPK) pathways, which increases mitogenesis and breast cancer risk.